Topics

.

Glioblastoma | Treatment | Targeted therapy | Anlotinib

Home > Publications > Topics > Glioblastoma > Treatment > Targeted therapy > Anlotinib

Li Y, Yang W, Ma X, Guo J, Li T, Zhou Z, Wang D, Yang J, Zhang Y, Wang Z, Yu K, Yu H.
Efficacy of Anlotinib in Treating Progressive Glioblastoma: Insights From a Single-Center Study.
Med Sci Monit. 2025 Sep 4;31:e948367. doi: 10.12659/MSM.948367. PMID: 41174836. Observational study. ˍ

Wu B, Zhang Z, Ma H, Huang J, Liu X, Shi L, Dong X, Lei D, Wang X, Zhang F, Zhao H, Lin H, Fu R, Zou Z, Qin Y, Wang H, Hu X, Yao D, Yang L, Yang J, Hong X, Wang J, Wen L, Zhang C, Liang Z, Yang Z, Nie X, Liu G, Hu F, Peng G, Jiang X, Yang K.
Postoperative anlotinib plus radiotherapy in patients with newly diagnosed, unmethylated O⁶-methylguanine-DNA methyltransferase glioblastoma: A single-arm, phase 2 study.
Cancer. 2026 Jun 24;132(13):e70502. doi: 10.1002/cncr.70502. PMID: 42339996. Trial registration ID: ChiCTR2000040116. ˍ